Kazia Therapeutics Ltd
KZIA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001075880
No open-market purchases or sales by Kazia Therapeutics Ltd insiders were filed in the last 90 days; 35 institutions reported holding it in 13F filings for Q2 2026, worth $50.7M in total; no superinvestor holds it.
13F holders, Q1 2024
Institutional positions in Kazia Therapeutics Ltd as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 11
- −7 vs. Q4 2023
- Shares held
- 371.2K
- −4.51M (−92.4%) vs. Q4 2023
- Total value
- $115.5K
- −$2.04M (−94.6%) vs. Q4 2023
- New holders
- 3
- 2 more added
- Sold out
- 10
- 4 more reduced
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting KZIA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 35 | $50.7M |
| Q1 2026 | 23 | $13.0M |
| Q4 2025 | 22 | $17.1M |
| Q3 2025 | 11 | $1.14M |
| Q2 2025 | 10 | $902.9K |
| Q1 2025 | 10 | $120.9K |
| Q4 2024 | 11 | $569.1K |
| Q3 2024 | 18 | $922.0K |
| Q2 2024 | 11 | $89.5K |
| Q1 2024 | 11 | $115.5K |
| Q4 2023 | 18 | $2.15M |
| Q3 2023 | 10 | $235.9K |
| Q2 2023 | 9 | $327.6K |
| Q1 2023 | 8 | $279.4K |
| Q4 2022 | 10 | $262.0K |
| Q3 2022 | 9 | $527.0K |
| Q2 2022 | 12 | $1.24M |
| Q1 2022 | 12 | $2.90M |
| Q4 2021 | 12 | $4.01M |
| Q3 2021 | 18 | $5.03M |
| Q2 2021 | 15 | $4.35M |
| Q1 2021 | 14 | $4.60M |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding Kazia Therapeutics Ltd; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Morgan Stanley | 197,850 | $61.3K | 0.00% | −3,700−1.8% | Reduced |
| HSBC Holdings PLC | 63,956 | $20.1K | 0.00% | −36,238−36.2% | Reduced |
| BNP Paribas Arbitrage, SA | 48,600 | $15.1K | 0.00% | +35,900+282.7% | Added |
| XTX Topco Ltd | 18,487 | $5.81K | 0.00% | −949−4.9% | Reduced |
| Two Sigma Securities, LLC | 18,424 | $5.71K | 0.00% | −39,999−68.5% | Reduced |
| Rhumbline Advisers | 12,170 | $3.83K | 0.00% | +2,460+25.3% | Added |
| Ground Swell Capital, LLC | 11,150 | $3.51K | 0.00% | +11,150 | New |
| Wells Fargo & Company | 500 | $155 | 0.00% | +500 | New |
| Allworth Financial LP | 87 | $27 | 0.00% | 00.0% | Unchanged |
| AdvisorNet Financial, Inc | 5 | $2 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 3 | $1 | 0.00% | +3 | New |
| Armistice Capital, LLC | 0 | $0 | 0.00% | −2,475,555−100.0% | Sold out |
| Platinum Investment Management Ltd | 0 | $0 | 0.00% | −1,821,887−100.0% | Sold out |
| Bank of Montreal | 0 | $0 | 0.00% | −140,166−100.0% | Sold out |
| Acadian Asset Management LLC | 0 | $0 | 0.00% | −18,682−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −12,809−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −11,449−100.0% | Sold out |
| GWM Advisors LLC | 0 | $0 | 0.00% | −500−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| McGlone Suttner Wealth Management, Inc. | 0 | $0 | 0.00% | −85−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −190−100.0% | Sold out |